Virgin Galactic: A Deep Value Investment Analysis

It is also highly dependent on key assets, key projects, and key milestones: dependent on the new Delta spaceship, dependent on FAA licensing and review timelines, dependent on Spaceport America and its operating conditions, dependent on a high-caliber flight and manufacturing team, and dependent on external capital markets continuing to provide funding. In its risk factors the company explicitly notes that FAA approval delays or added conditions could affect the timeline to resume commercial flight; it also states plainly that losing key executives could harm execution; and at the brand level, even the "Virgin" brand itself is not fully controlled by the company.

From the standpoint of "is it easy to understand," the product is easy to understand, but the unit economics are not. I give "business comprehensibility" a score of 2/5: you can grasp what it sells, but you cannot, today, infer from historical financials how it will reliably make money in the future. If the stock market were to close for five years, I would not be willing to hold this business as a settled piece of ownership on the current evidence alone.

Industry and competitive landscape

This industry is still in a very early, validation stage and cannot be called mature. It has long-term imaginative potential, but the near-term reality is: demand is highly niche, the product is very expensive, regulation is heavy, the margin for error is extremely thin, and any accident could simultaneously damage regulation, demand, and the financing environment. The company itself concedes that it is now concentrated mainly on a single, discretionary product category: commercial spaceflight, and is vulnerable to economic downturns, falling consumer confidence, and negative publicity.

Long-term demand is not nonexistent, but it is not stable either. As of year-end 2025 the company had roughly 675 future astronauts in backlog; and back in 2024 it gave a target: the first two Delta vehicles could support roughly 125 flights per year on an annualized basis, with each Delta designed for 6 passenger seats. By that design, a rough calculation puts full-load annual seat supply at about 750 seats per year. This means that, on the company's own disclosed backlog, there is roughly enough to cover less than one year of full-load capacity. That is my own estimate, not a direct company statement, but it matters: SPCE's long-term value is not just "flying off the old orders," but continuously finding new high-net-worth customers and sustaining repeat purchases and reputation under high safety standards.

On competition, Virgin Galactic states in its 10-K that its principal competitor is Blue Origin. Blue Origin's official site shows that the New Shepard program completed its 12th human spaceflight in May 2025, and in January 2026 completed its 38th New Shepard mission; but on January 30, 2026 Blue Origin also announced that New Shepard would pause flights for no less than two years, redirecting resources toward developing human lunar flight capability. In the short term, this does ease the direct competitive pressure on Virgin Galactic; but over the long term it does not constitute a moat, because Blue Origin has stronger capital backing, technology stack, and organizational capability — it has merely temporarily shifted resources elsewhere.

So this industry is not "a good company in a good industry," but more like a high-technology, high-barrier, early-stage industry whose economic returns have yet to be proven. Within that frame, even if the company is a first mover, that does not automatically make it a good business worth acquiring for the long term. I give "industry attractiveness" a score of 2/5: the imaginative potential is large, but for a long-term value investor the verifiability is too weak and the cash returns are too far off.

Moat and Management

Moat analysis

Virgin Galactic has some "thresholds," but it is hard to say a genuine "moat" has formed.

On brand advantage, the Virgin brand does carry appeal around experience, adventure, and luxury, and the company repeatedly emphasizes its end-to-end customer journey and astronaut community; but the company itself warns that the Virgin brand is not within its control, and negative publicity could backfire on the business. So the brand is a plus, but not a solid moat.

A cost advantage is currently not visible. The company claims the Delta design targets are easier maintenance, higher reusability, and lower per-flight cost, and even calls it the "highest-capacity, lowest-cost human-rated space vehicle"; but this remains a management target, not a historical fact. Current financial performance argues the opposite: the company is still far from a cost advantage.

A scale advantage has not yet formed either. Virgin Galactic has flown only a limited number of missions to date, with 23 paying astronauts flown as of year-end 2025; it is still quite far from "scaled operations." The company does say a steady-state Delta could achieve two flights per vehicle per week, but this depends on manufacturing, testing, licensing, flight safety, and ground operations all delivering as planned across multiple links.

Network effects, switching costs, channel advantages, and data advantages are all weak. What customers buy is a single high-risk, high-price experience, with no typical network effect; nor do customers face high "switching costs," because the whole market is small to begin with and the alternatives are limited but not zero; and on channels, although the company uses luxury travel agencies, there is no irreplaceable distribution barrier in sight.

What is genuinely more valuable is the patents/licenses/regulatory barrier plus long-term accumulated R&D. In its 10-K the company stresses that entering commercial crewed suborbital flight requires years of high-risk development and large capital investment, and says it knows of only one operator that has invested comparable time and money in a suborbital human commercial flight platform; the FAA also officially confirms that it regulates commercial crewed flight through licensing, verification, inspection, and airspace safety integration. In other words, this is not an industry anyone can replicate tomorrow. The problem is: a high barrier does not equal high economic returns. In many industries, the entry barrier is precisely what devours return on capital.

On trend, I believe this "moat" is not widening, but waiting to be validated. If Delta flies smoothly, flies often, flies cheaply, and without a major accident, its technical and operational accumulation may begin to convert into a moat; but until then, it looks more like "large sunk cost." A rival seeking to replicate it might indeed need years and enormous capital, but what investors care about is not "how hard it is for others to replicate," but "whether this company can ultimately make real money." I give "moat strength" a score of 1/5.

On pricing, inflation resistance, and recession resistance: the company has indeed raised its list price several times, from $450,000 to $600,000 to $750,000, which shows it has room to raise prices in theory; but because flight frequency and delivery are not yet stable, this cannot be equated with mature-consumer-brand pricing power. On the contrary, the company itself admits the product is discretionary, that downturns weaken demand, and that the company is currently not profitable at all — so there is no "staying profitable through a downturn" to speak of. The past "high imagination" and occasional high seat revenue are not structurally high margins, but more like early supply-demand mismatch or a scarcity premium.

Management and capital allocation

Is management honest? I would give a partial yes. At least on disclosure quality, the company stated plainly in its 2025 annual report and its Q1 2026 filing that substantial doubt exists about its ability to continue as a going concern, and explained that management's proposed mitigation plans are insufficient to eliminate that doubt. That candor itself deserves a small added point.

But on "is capital allocation excellent," my assessment is clearly lower. Over the past few years the company has essentially walked a path of continuous cash burn plus continuous share issuance plus complex refinancing: the 2023 ATM program sold a total of 12.8 million shares for $396.2 million; the 2024 ATM program had sold a cumulative 37.6 million shares for $150.7 million by year-end 2025; by the end of March 2026 it had sold a cumulative 41.6 million shares, and in April 2026 it sold another 18.1 million shares, raising a further $51.6 million. Looking from 32.996 million shares at year-end 2024 to 100.68 million shares on May 7, 2026, the share base ballooned dramatically in a short time.

The late-2025 recapitalization also reflects a "buy time to survive" mindset: the company used newly issued common stock, prepaid warrants, 9.80% secured notes due 2028, and 31.7 million purchase warrants to repurchase the original 2027 convertibles, indeed reducing debt-maturity pressure by roughly $142 million; but the price was a higher interest rate, asset collateral, and potentially greater dilution. As a survival maneuver it is not necessarily irrational; but as shareholder capital allocation, it can hardly be called excellent.

Are management and shareholders highly aligned? On holdings, not strongly. As of March 31, 2026, CEO Michael Colglazier beneficially owned roughly 343,095 shares, and all current directors and officers combined owned roughly 732,822 shares, both less than 1% of the company's then-outstanding 81,409,340 shares. That is far from a "heavily invested owner-operator."

Now compensation. 2025 CEO total compensation was roughly $10.746 million, which also included a $1.25 million retention bonus paid in 2025; the company's 2025 net loss was $278.9 million and free cash flow roughly -$438.1 million. I do not deny that an aerospace program needs top management talent, and I understand milestone-style retention incentives; but for a company that has yet to prove its business model and still needs large-scale financing, this compensation level makes it hard for me to give a high score.

More importantly, a substantial part of the company's operating improvement comes from development activities shifting from expense to capitalized investment. In its 2026 Proxy, under "2025 Highlights," the company states plainly that total 2025 operating expenses fell partly because "research and development expense decreased, one reason being that development activity shifted toward investment in assets such as manufacturing capacity and spaceships." In other words, the income statement looks somewhat better, but that does not mean economic reality is any easier — much of the spending simply moved from current-period expense into capital expenditure. For long-term shareholders, this point is very important.

On balance, I give "management and capital allocation" a score of 2/5: disclosure is reasonably candid, but the protection of per-share intrinsic value for shareholders is low, and capital allocation leans more toward "extending runway" than "raising return on capital."

Financial Quality and Owner Earnings

Key financial quality

The table below summarizes what I consider the most critical financial metrics. Two notes first: first, the company does not separately disclose a standard GAAP "gross profit," so I place more weight on operating loss, operating cash flow, and free cash flow; second, between 2021-2023 and 2024-2026 there was a reverse stock split and changes in project accounting, so the comparability of share-related metrics is limited. The figures in the table are the company's original disclosed numbers, and I separately calculate FCF = operating cash flow − CapEx.

The 2021 figures come from the 2021 10-K; the 2022-2023 figures from the 2023 10-K; the 2024-2025 figures from the 2025 10-K; and the 2026Q1 figures from the Q1 2026 filing.

The most critical conclusion from this table is not "how much it lost," but the structure of the loss. The company's cumulative net loss from 2021 to 2025 exceeded $1.9 billion, and free cash flow was worse than net loss in every full year, showing that the accounting loss did not overstate the pain — it actually understated the cash burn. Take 2024 and 2025 especially: net losses of roughly $347 million and $279 million, but FCF of roughly -$475 million and -$438 million. In other words, it is not "weak accounting profit, decent cash," but "cash reality worse than accounting."

Revenue growth quality is also very poor. Revenue in 2023 and 2024 was only about $7 million each, and in 2025 it fell to $1.544 million; Q1 2026 was only $227,000. If you treat it as a growth stock, the biggest obstacle is not "slow growth," but that growth has not yet happened on a sustained basis.

Return on capital is essentially beyond discussion. Because EBIT and net income are persistently negative, ROE, ROA, and ROIC are persistently negative too. 2025 debt/assets was roughly 65.9%, rising further to roughly 70.2% by Q1 2026; current assets were $283.5 million and current liabilities $282.6 million, with liquidity nearly at the edge. Net debt/EBITDA and interest coverage are not analytically meaningful because EBITDA and EBIT are negative.

On working capital, what matters most is not receivables but customer deposits and payables. Customer deposits declined overall — from $102.6 million at year-end 2022, to $97.8 million at year-end 2023, to $84.49 million at year-end 2024, to $78.54 million at year-end 2025, and to $77.95 million in Q1 2026; payables, meanwhile, rose from $3.696 million at year-end 2024 to $15.163 million at year-end 2025, and continued to $17.041 million in Q1 2026. This shows that backlog has not converted into an increasingly solid cash reservoir, but instead slipped somewhat during the flight suspension.

Share-count change is especially worth watching. Shares issued and outstanding were roughly 32.996 million at year-end 2024, became 73.327 million at year-end 2025, 81.409 million at the end of March 2026, and reached 100.68 million by May 7, 2026. Not to mention that the company still carries 31.7 million purchase warrants with an exercise price of $6.696, exercisable from June 18, 2026 through the end of 2030. For long-term investors, this means that even if the business eventually succeeds, per-share value may continue to be diluted by financing.

I have not seen, in the materials I reviewed, the crude signatures of "stuffing revenue via receivables" or "smoothing profit to manufacture prosperity"; on the contrary, its core problem is more direct: the business model has not yet been proven out. But I will stay alert to two kinds of accounting-quality issues: first, after development activity shifts from expense to capitalization, whether the income-statement improvement is merely "accounting relocation"; and second, whether the accounting treatment of complex financing instruments, debt premiums, and warrants obscures the true per-share economic cost.

Owner Earnings analysis

On a Buffett-style "owner earnings" approach, I would estimate very conservatively.

For 2025, the company's net loss was -$278.9 million; the main non-cash items to add back include stock-based compensation of $18.698 million, depreciation and amortization of $16.485 million, plus a small amount of other non-cash items. Looking only at operating cash flow, 2025 was -$240.1 million. The problem is that the company's CapEx ran as high as $198.0 million, and per the company's own disclosure these outlays relate mainly to the next-generation spaceship; in other words, this is not "optional growth capex" that can be easily cut, but the economic investment the company must bear to survive and to realize future revenue. So on a conservative basis, 2025 owner earnings is approximately operating cash flow − maintenance CapEx ≈ -$438 million.

Strictly speaking, maintenance CapEx and expansion CapEx are very hard to separate precisely here. But for a company like SPCE that has not finished its commercialization ramp, if you treat a large amount of Delta spending as "pure growth capex" and exclude it from owner earnings, you will overstate the company's true distributable cash — because without that spending, the current business model has no going-concern capability at all. So I deliberately adopt a more conservative treatment here: most Delta-related capex should, in economic terms, be regarded as "necessary to maintain the company's eligibility to survive in the future."

By the same logic for Q1 2026: net loss -$64.715 million, operating cash flow -$53.501 million, CapEx -$39.830 million, and company-defined free cash flow of roughly -$93.3 million. This again shows that at this stage owners have no "distributable cash flow," but are continuously injecting more capital into the company.

So my conservative owner-earnings estimate is: roughly -$438 million for 2025; and if 2026 is annualized from Q1, roughly -$370 million to -$400 million. On this basis, the current valuation is not "a multiple of owner earnings," but a forward-looking bet on negative owner earnings. That is exactly the opposite of what traditional value investing most prefers — discounting verifiable cash flow.

Intrinsic Value, Valuation, and Margin of Safety

Current valuation snapshot

As of June 3, 2026 (U.S. Eastern), SPCE traded around $4.29. One thing worth flagging specifically: market data sources show a market cap of roughly $341 million, but the company's Q1 2026 filing disclosed that shares outstanding had reached 100,683,438 as of May 7, 2026; multiplying $4.29 by this SEC-disclosed share count puts equity value closer to $432 million. In the valuation below I lean toward using the latest SEC share count, because the company has indeed kept issuing shares via the ATM over recent months, and some data vendors may lag.

Discounted owner-earnings method

A traditional DCF is inherently unstable for a company whose current owner earnings is deeply negative and whose management discloses going-concern doubt. So I treat it as "scenario analysis" rather than precise valuation.

Conservative scenario: Delta testing/commercialization is further delayed, owner earnings stays significantly negative across 2026-2028, the company depends on continued financing, and per-share value is further diluted. In this case, intrinsic value to existing shareholders is mainly close to "residual asset value" rather than operating value. Under this scenario, I put equity value at roughly $0–1 per share.

Neutral scenario: Delta launches commercial service in Q4 2026, the second vehicle enters service around 2027, but the ramp is slower than optimistic expectations; only in 2028-2030 does it gradually approach positive but modest owner earnings. Considering recent continuous share issuance and potential future warrant dilution, I think a reasonable value to current shareholders is roughly $1–3 per share. This range already implies management at least completing the combination of "on-time commercial flight + sustained flights + no catastrophic capital-market dilution."

Optimistic scenario: the first Delta is validated on schedule, the second follows quickly, flight frequency and load factors steadily improve, the direction management gave in 2024 — "the first two Delta vehicles supporting roughly 125 flights per year and an annualized revenue run-rate of about $450 million" — is broadly delivered, and subsequent capex falls back from a build phase to a maintenance phase. Under this scenario, I think equity value could reach $3–5.5 per share, but this already requires a lot of "good things happening," while also keeping financing dilution, zero tolerance for accidents, demand continuation, and other variables under control.

Through this DCF/owner-earnings frame, the current $4.29 is not a price "cheap enough to give you room for error," but more like a market already paying for a fairly optimistic execution path.

Relative valuation method

Relative valuation is very hard to use here. The reason is not computational hassle, but that most of the key denominators do not hold: SPCE's PE is currently negative, EV/EBITDA is negative or meaningless, P/FCF is negative, and ROIC is negative too. Putting a company with no positive earnings and no positive FCF into a traditional valuation-multiple frame is itself prone to creating illusions.

Even comparing against a group of public-market "new space" companies, the problem is similar: Rocket Lab, Redwire, and Intuitive Machines all currently have negative PE as well. That fact can only tell you "many companies in this sector are immature"; it cannot tell you SPCE is cheap. If peers also lack stable profitability, then "peers are expensive/loss-making too" is not a reason to buy.

On several more straightforward relative metrics, SPCE is not cheap either. On the latest SEC share count, current equity value is roughly $432 million; yet 2025 revenue was only $1.544 million, so even on a looser enterprise-value basis (equity value + debt − cash and securities), EV is distortedly high relative to 2025 revenue. Relative to book net assets, on Q1 2026 shareholders' equity of $223.7 million, current P/B is roughly 1.9x, which is not cheap for a high-burn company that has yet to prove commercial sustainability.

Asset or liquidation value method

This is the floor-valuation method I consider most useful for SPCE.

As of March 31, 2026, the company had cash, cash equivalents, and restricted cash of $155.5 million and marketable securities of $95.1 million, totaling roughly $250.5 million; contractual debt principal was roughly $282.9 million. If you take only "financial assets minus debt principal" as the most simplified liquidation floor, it is already negative. And if you further account for payables, other current liabilities, long-term other liabilities, and the potential refund pressure from customer deposits, then the on-balance-sheet liquid financial assets alone can hardly support adequate shareholder liquidation value.

Of course, the company also has $426.7 million net of property, plant, and equipment. But these are highly specialized aerospace and manufacturing assets with a high probability of distressed disposal, and the 2028 notes also place a first-priority lien on substantially all assets of the company and its domestic subsidiaries. So without assuming business success, PP&E is not a "solid book-value cushion" for common shareholders.

On that basis, I would rather give the following set of ranges than pretend I can compute to two decimal places:

This range is based collectively on the company's liquidity, debt, capex intensity, commercialization timeline, backlog, and management's past target statements on Delta capacity/revenue.

On that basis, the current price of roughly $4.29 is clearly expensive relative to my reasonable intrinsic value range, and against the optimistic range leaves only a very limited cushion. Put differently, it has no margin of safety, only optimistic expectations. I think a sufficiently conservative buy precondition should rest on at least one of two things: "price significantly below $2," or "commercial validation significantly better than today." On pure numbers, if a range must be given, I would view it this way:

Risks, the Bear Case, and Opportunity Cost

The most important risks and the strongest bear case

The most important risk in this investment is not "high volatility," but permanent loss of capital.

The first category is execution and safety risk. Any major accident, mechanical failure, or below-expectation flight-test result would simultaneously hit regulatory progress, order confidence, and financing capacity. The company itself explicitly warns that any public accident involving itself, a competitor, or the aviation industry could harm public perception of spaceflight; and its insurance may not be sufficient to cover the exposure.

The second category is financing and dilution risk. The company disclosed substantial going-concern doubt in both its 2025 annual report and its Q1 2026 filing, and explicitly listed "further equity or debt financing," "settling debt with equity," and "extending debt maturities" as mitigation measures. For existing shareholders, this means the company may survive, but per-share value is not necessarily preserved.

The third category is economic-model risk. Even if Delta makes its first flight on time, that does not equal being profitable on time. What truly determines value is whether, per flight, the company can cover rocket-motor replacement, maintenance, ground operations, training, insurance, sales, and fixed costs, and still leave cash after accounting for maintenance capex. The historical financials have not proven this at all.

The fourth category is demand-stability risk. This is not utilities, nor must-have software, but discretionary, expensive, strongly confidence-driven ultra-high-end experiential consumption. Backlog is refundable, the pricing structure of existing orders is mixed, and on the Delta capacity target the company gave earlier, current backlog by itself cannot prove stable demand over the coming years.

The strongest bear case can be summed up in one sentence: SPCE is not a "cheap Buffett stock," but a "still-financing aerospace project company"; if key timelines slip again over the next two to three years, common shareholders could lose most of their per-share economic interest even as the company survives. This is also what I think the bears genuinely see: they are not necessarily betting that "the spaceship can't fly," but that "even if it flies, shareholders may not make money."

If the following facts occur, I would consider any prior positive-leaning investment judgment overturned: first, the first Delta commercial flight is again clearly pushed past 2027; second, continued large-scale ATM issuance without materially improving unit economics; third, a major safety incident or FAA approval/added conditions that set back the commercial-flight cadence; and fourth, orders/deposits continue to decline while the new list prices do not convert into actual transactions. All of these would significantly raise the probability of permanent loss of capital.

Comparison with other opportunities

Comparing SPCE to its strongest direct competitor: Blue Origin is a private company and cannot be directly compared on equity multiples; but Blue Origin has at least repeatedly completed New Shepard missions, reaching its 38th mission before January 2026, only then choosing to pause New Shepard for two years and direct resources toward lunar missions. For Virgin Galactic, this means lighter short-term competition; but on capital strength and platform breadth, Virgin Galactic does not hold the advantage.

Comparing SPCE to a broad-based index, I cannot see it being clearly superior on a risk-adjusted basis to buying SPY. SPY represents a broad portfolio of profitable, listed companies with more verifiable cash flow; whereas SPCE is still in the stage of "validating a single project plus depending on capital markets." For balanced, conservative capital, this opportunity cost is very high.

Comparing it to the risk-free rate, on June 3, 2026 the U.S. 10-year Treasury constant-maturity yield was roughly 4.34%. To make me give up a long-term rate instrument yielding a nominal 4%-plus with extremely low credit risk, in order to take on SPCE's going-concern doubt, negative FCF, potential dilution, and highly interlinked safety/regulatory risk, I would need at least an expected return clearly above the risk-free rate and more verifiable. On today's evidence, I do not see it.

So if I could only hold 5 assets, it would not qualify to enter a conservative long-term portfolio. For that kind of portfolio, SPCE is not a "high-odds, low-risk" opportunity, but a "high-story, high-risk, and not-necessarily-high-enough-odds" one.

Open questions and limitations

I have three explicit reservations about this research. First, there is no truly comparable publicly listed, pure suborbital crewed spaceflight peer, so relative valuation is inherently weak. Second, the company has not publicly disclosed sufficiently granular Delta unit-economics data, so all valuations must use fairly wide ranges. Third, the SPCE market cap given by market data sources differs from the latest SEC share count; I gave priority to the SEC share count in valuation, but this will cause the "current market cap" to vary across different data terminals.

Checklist and Final Investment Conclusion

Investment checklist

This checklist is a compressed synthesis of the financial, management, industry, moat, and valuation evidence above. The core conclusion is unchanged: it looks more like a high-technology project still needing financing than a quality company that has already proven itself worth acquiring for the long term.

Final investment conclusion

【Final Rating】 Avoid.

【One-Sentence Investment Thesis】 Virgin Galactic sells a highly imaginative spaceflight experience, but to this day it has still not proven it can convert that experience into stable, distributable, shareholder-friendly cash flow.

【Core Bull Case】

• Entry barriers are high and the industry is not easily replicated; the FAA license, years of accumulated R&D, and proprietary manufacturing/operating capability are genuinely real.

• The Virgin brand, the scarcity of space travel, and early-market mindshare do give the company a chance to hold attention in high-end experiential consumption.

• Blue Origin's two-year pause of New Shepard eases direct competitive pressure in the near term.

• If Delta delivers smoothly, the company could in theory move from "low-frequency validation" to "high-frequency commercial operation," with management having given a target direction of 125 flights per year and a $450 million run-rate for the first two Delta vehicles.

• Unity resumed glide flights in May 2026, showing the team is preparing for new-vehicle testing and operations and that execution is not stalled.

【Core Bear Case】

• The latest 10-K and 10-Q both state plainly that substantial doubt exists about the ability to continue as a going concern.

• Revenue is tiny, only $1.544 million in 2025, while 2025 FCF was roughly -$438 million; Q1 2026 FCF was roughly -$93.3 million.

• The share count expanded dramatically over the past two years, with 31.7 million warrants still overhanging; even if the business survives, common shareholders' per-share value may continue to be diluted.

• Part of the income-statement improvement comes from capitalizing spending rather than self-generated operating cash, and economic reality remains tight.

• The current price already bets substantially on Delta delivering successfully, without giving enough room for error.

【Key Assumptions】

• New-vehicle glide/test progress advances on plan in Q3 2026, with the first commercial flight beginning in Q4.

• The second new vehicle can enter service around Q4 2026 to Q1 2027.

• Future financing will not severely impair per-share value through overly heavy dilution or worse debt terms.

• New ticket prices and new orders can genuinely convert into non-refundable, executable, profitable mission revenue.

• No major safety accident or delay causes dual damage to regulation and brand.

【Fair Buy Price】 If a number must be given, I think the more attractive zone is around $1–1.5, while still watching commercial validation in parallel; if the price has merely fallen but Delta execution and financing conditions deteriorate, even that range may not be cheap enough. On today's known information alone, $4.29 does not constitute a reasonable buy point.

【Target Holding Period】 Given the nature of the business, if one were to invest, it can only be understood as a 5–10 year high-risk project cycle; but for your risk appetite and goals, I lean toward not entering rather than buying first and waiting.

【Expected Annualized Return】

• Conservative scenario: if there are delays, continued dilution, and value approaching residual assets, the annualized return over the next 10 years could be roughly -20% to -8%.

• Neutral scenario: if commercial flight goes smoothly but economics are mediocre, the annualized return over the next 10 years could be roughly -3% to +2%.

• Optimistic scenario: if Delta cadence, unit economics, and financing conditions are all clearly better, the annualized return over the next 10 years might reach +6% to +11%; but I think this already requires many optimistic assumptions to hold at once.

【Maximum Loss Risk】 The worst case is not a short-term halving of the stock price, but common-stock value approaching zero: if testing/commercial flight keeps slipping, the capital-market environment turns worse, or a major safety or regulatory setback occurs, the company could be forced to raise capital in ways extremely unfriendly to old shareholders, and under asset-secured debt priority could even leave common stock with very little residual value.

【Tracking Metrics】

• Whether new-vehicle Delta glide/testing advances on schedule in Q3 2026.

• Whether the first new-vehicle commercial flight remains on track for Q4 2026.

• Whether the second vehicle remains on track to enter service in Q4 2026 to Q1 2027.

• Quarterly operating cash flow, CapEx, and free cash flow.

• The coverage ratio of cash and securities against debt principal over the next 12 months.

• Shares outstanding, ATM usage cadence, and whether worse financing terms are added.

• Changes in backlog, customer deposits, and non-refundable orders.

• Actual per-seat revenue, actual flight frequency, and per-mission contribution profit.

• Any safety incident, FAA approval change, or added conditions.

【Signals That Trigger Reassessment】

• The Delta timeline is again materially delayed.

• Free cash flow does not improve over the next two quarters while the share base keeps expanding rapidly.

• A major safety accident or regulatory restriction.

• Backlog/deposits continue to bleed, indicating that high-end demand has not firmed up in line with the price increases.

• Management again swaps short-term liquidity for high-cost debt or large-scale warrants.

【Final Recommendation】 If you are genuinely making a 10-year decision from a "buying a business" standpoint, my recommendation is: do not buy now. It is not too late to revisit once at least two of the following three things have happened: first, Delta enters commercial flight on plan and operates safely; second, the company's quarterly free cash flow converges significantly, proving that "scaling up" is not "scaling up the cash burn"; and third, financing dependence drops clearly, indicating that future returns are more likely to stay with shareholders rather than the next capital provider. For balanced, conservative capital, staying disciplined matters more than betting on a business curve that has not yet been proven out.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.